Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors (Q40321046)

19 September 2017

Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors (English)

1 reference

19 September 2017

0 references

1 reference

VanOosten RL

1

1 reference

19 September 2017

Earel JK Jr

series ordinal

2

1 reference

19 September 2017

Griffith TS

series ordinal

3

1 reference

19 September 2017

1 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

6

1 reference

19 September 2017

628-632

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700939

19 September 2017

0 references

cites work

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

A simple method for the rapid generation of recombinant adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Acetylation of general transcription factors by histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

The emerging role of class II histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

inferred from DOI database lookup

7 January 2021

based on heuristic

Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700939

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700939

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference